Home
AIM ImmunoTech AIM paid Buchanan Ingersoll & Rooney PC $20K for lobbying in Q4 2024 · Pharmacy, Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $20,000
- Quarter
- Q4 2024
- Stock
- AIM ImmunoTech AIM
- Client
- Aim Immunotech
- Reported
- 25/01/16
Up 0.0% from last quarter
What else happened in AIM ImmunoTech around then
Filed or reported within 30 days of the trade day · 24/12/01~25/01/30Aim Immunotech's other lobbying reports
- Aim Immunotech
LobbyingAIM ImmunoTech
LobbyingAIM ImmunoTech
AIM
Under $5,000
Under $5,000
Reported 01/20
for Q4 2025
- Aim Immunotech
LobbyingAIM ImmunoTech
LobbyingAIM ImmunoTech
AIM
Under $5,000
Under $5,000
Reported 25/10/15
for Q3 2025
- Aim Immunotech
LobbyingAIM ImmunoTech
LobbyingAIM ImmunoTech
AIM
$20K
$20K
Reported 25/07/17
for Q2 2025
- Aim Immunotech
LobbyingAIM ImmunoTech
LobbyingAIM ImmunoTech
AIM
$20K
$20K
Reported 25/04/02
for Q1 2025
- Aim Immunotech
LobbyingAIM ImmunoTech
LobbyingAIM ImmunoTech
AIM
$20K
$20K
Reported 24/10/10
for Q3 2024